Provided by Tiger Fintech (Singapore) Pte. Ltd.

Entrada Therapeutics, Inc.

7.16
+0.19002.73%
Post-market: 7.160.00000.00%16:11 EDT
Volume:169.53K
Turnover:1.21M
Market Cap:271.75M
PE:11.80
High:7.27
Open:7.01
Low:7.01
Close:6.97
Loading ...
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Sep 29, 2023

Major Issues Report

Form 8-K - Current report
Sep 21, 2023

Major Issues Report

Form 8-K - Current report
Sep 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 06, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Aug 08, 2023

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2023

Major Issues Report

Form 8-K - Current report
Jul 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities